New frontiers in the pathology and therapy of heart valve disease: 2006 Society for Cardiovascular Pathology, Distinguished Achievement Award Lecture, United States-Canadian Academy of Pathology, Atlanta, GA, February 12, 2006

Cardiovascular Pathology

Volumn 15, Issue 5, 2006, Pages 271-279

  Schoen, Frederick J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Engineering and regeneration; Heart valve; Valvular heart disease

Indexed keywords

CANADA; EVOLUTION; HEART VALVE PROSTHESIS; HUMAN; HUMAN TISSUE; MITRAL VALVE REGURGITATION; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGENERATION; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE ENGINEERING; VALVULAR HEART DISEASE;

HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; TISSUE ENGINEERING;

EID: 33748413049     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2006.05.001     Document Type: Review

References (95)

1. Schoen F. Cardiac valves and valvular pathology. Update on function, disease, repair, and replacement. Cardiovasc Pathol 14 (2005) 189-194
2. Schoen F. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis 6 (1997) 1-6
3. Yacoub MH, Cohn LH. Novel approaches to cardiac valve repair. From structure to function: parts I and II. Circulation 2004;109:942-950, 1064-1072.
4. Rabkin-Aikawa E., Mayer J., and Schoen F. Heart valve regeneration. Adv Biochem Eng Biotechnol 94 (2005) 141-179
5. Vesely I. Heart valve tissue engineering. Circ Res 97 (2005) 743-755
6. Eisenberg L., and Markwald R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77 (1995) 1-7
7. Armstrong E., and Bischoff J. Heart valve development. Endothelial cell signaling and differentiation. Circ Res 95 (2004) 459-470
8. Schroeder J., Jackson L., Lee D., and Camenisch T. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 81 (2003) 392-403
9. Gitler A., Lu M., Jiang Y., Epstein J., and Gruber P. Molecular markers of cardiac endocardial cushion development. Dev Dyn 228 (2003) 643-650
10. Gimbrone M., Topper J., Nagel T., Anderson K., and Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann NY Acad Sci 902 (2000) 230-239
11. Garcia-Cardena G., Comander J., Anderson K., Blackman B., and Gimbrone M. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci U S A 98 (2001) 4478-4485
12. Shin D., Garcia-Cardena G., Hayashi S., Gerety S., Asahara T., Stavrakis G., Isner J., Folkman J., Gimbroner M., and Anderson D. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult revascularization. Dev Biol 230 (2001) 139-150
13. Kadner A., Chen R., Mitchell R., and Adams D. Homograft crossmatching is unnecessary due to the absence of blood group antigens. Ann Thorac Surg 71 (2001) S349-S352
14. Davies P., Passerini A., and Simmons G. Aortic valve: turning over a new leaf (let) in endothelial phenotypic heterogeneity. Arterioscler Thromb Vasc Biol 24 (2004) 1331-1333
15. Butcher J., Tressel S., Johnson T., Turner D., Sorescu G., Jo H., and Nerem R. Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: influence of shear stress. Arterioscler Thromb Vasc Biol 26 (2006) 69-77
16. Butcher J., Penrod A., Garcia A., and Nerem R. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol 24 (2004) 1429-1434
17. Simmons C., Grant G., Manduchi E., and Davies P. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res 96 (2005) 792-799
18. Mulholland D., and Gotlieb A. Cell biology of valvular interstitial cells. Can J Cardiol 12 (1996) 231-236
19. Taylor P., Batten P., Brand N., Thomas P., and Yacoub M. The cardiac valve interstitial cell. Int J Biochem Cell Biol 35 (2003) 113-118
20. Rabkin-Aikawa E., Aikawa M., Farber M., Kratz J., Garcia-Cardena G., Kouchoukos T., Mitchell M., Jones R., and Schoen F. Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site. J Thorac Cardiovasc Surg 128 (2004) 552-561
21. Walker G., Masters K., Shah D., Anseth K., and Leinwand L. Valvular myofibroblast activation by transforming growth factor beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 95 (2004) 253-260
22. Rabkin-Aikawa E., Farber M., Aikawa M., and Schoen F. Dynamic and reversible changes of interstitial cell phenotype during development and remodeling of cardiac valves. J Heart Valve Dis 13 (2004) 841-847
23. Durbin A., and Gotlieb A. Advances towards understanding heart valve response to injury. Cardiovasc Pathol 11 (2002) 69-77
24. Merryman W., Youn I., Lukoff H., Krueger P., Guilak F., Hopkins R., and Sacks M. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol 290 (2006) H224-H231
25. Kershaw J., Misfeld M., Sievers H., Yacoub M., and Chester A. Specific regional and directional contractile responses of aortic cusp tissue. J Heart Valve Dis 13 (2004) 798-803
26. Merryman W., Huang H., Schoen F., and Sacks M. The effects of cellular contraction on aortic valve leaflet flexural stiffness. J Biomech 39 (2006) 88-96
27. Aikawa E., Whittaker P., Farber M., Mendelson K., Padera R., Aikawa M., and Schoen F. Human semilumar cardiac valve remodeling by activated cells from fetus to adult. Circulation 113 (2006) 1344-1352
28. Christie G., and Barratt-Boyes B. Age-dependent changes in the radial stretch of human aortic valve leaflets determined by biaxial testing. Ann Thorac Surg 60 1 (1995) 156-158
29. Horne B., Camp N., Muhlestein J., and Cannon-Albright L. Evidence for a heritable component in death resulting from aortic and mitral valve disease. Circulation 110 (2004) 3143-3148
30. Rossebo A., and Pedersen T. Hyperlipidaemia and aortic valve disease. Curr Opin Lipidol 15 (2004) 447-451
31. Towbin J., and Belmont J. Molecular determinants of left and right outflow tract obstruction. Am J Med Genet 97 (2000) 297-303
32. Weyman A., and Scherrer-Crosbie M. Marfan syndrome and mitral valve prolapse. J Clin Invest 114 (2004) 1586-1592
33. Fedak P., David T., Borger M., Verma S., Butany J., and Weisel R. Bicuspid aortic valve disease: recent insights in pathophysiology and treatment. Expert Rev Cardiovasc Ther 3 (2005) 295-308
34. Roberts W., and Ko J. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111 (2005) 920-925
35. Cripe L., Andelfinger G., Martin L., Shooner K., and Benson D. Bicuspid aortic valve is heritable. J Am Coll Cardiol 44 (2004) 138-143
36. McBride K., Pignatelli R., Lewin M., Ho T., Fernbach S., Menesses A., Lam W., Leal S., Kaplan N., Schliekelman P., Towbin J., and Belmont J. Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: segregation, multiplex relative risk, and heritability. Am J Med Genet A 134 (2005) 180-186
37. Garg V., Muth A., Ransom J., Schluterman M., Barnes R., King I., Grossfeld P., and Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 437 (2005) 270-274
38. Schoen F. The heart. In: Kumar V., Fausto N., and Abbas A. (Eds). Robbins/Cotran pathologic basis of disease. 7th ed (2004), Saunders, Philadelphia 555
39. Freeman R., and Otto C. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111 (2005) 3316
40. Kim K. Apoptosis and calcification. Scanning Microsc 9 (1995) 1137
41. Otto C., et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histological and immunohistochemical studies. Circulation 90 (1994) 844
42. Demer L. Mineral explorations: search for the mechanism of vascular calcification and beyond. Arterioscler Thromb Vasc Biol 23 (2003) 1739-1743
43. Mohler E. Mechanisms of aortic valve calcification. Am J Cardiol 94 (2004) 1396-1402
44. Cowell S., Newby D., Prescott R., Bloomfield P., Reid J., Northridge D., Boon N., Scottish Aortic Stenosis and Lipid Lowering Trial, and Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352 (2005) 2389
45. Verma S., Szmitko P., Fedak P., Errett L., Latter D., and David T. Can statin therapy alter the natural history of bicuspid aortic valves?. Am J Physiol Heart Circ Physiol 288 (2005) H2547
46. Hayek E., Gring C., and Griffin B. Mitral valve prolapse. Lancet 365 (2005) 507-518
47. Freed L., Levy D., Lavine R., Larson M., Evans J., Fuller D., Lehman B., and Benjamin E. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341 (1999) 1-7
48. Aoyama T., Francke U., Gasner C., and Furthmayr H. Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders. Am J Med Genet 58 (1995) 169-176
49. Roberts R. Another chromosomal locus for mitral valve prolapse: close but no cigar. Circulation 112 (2005) 1924-1926
50. Rabkin E., Aikawa M., Stone J., Fukumoto Y., Libby P., and Schoen F. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104 (2001) 2525-2532
51. Ng C., Cheng A., Myers L., et al. TGF-β-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114 (2004) 1586-1592
52. Trochu J., Kyndt F., Schott J., Gueffet J., Probst V., Benichou B., and Le Marec H. Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to Xq28. J Am Coll Cardiol 35 (2000) 1890-1897
53. Freed L., Acierno J., Dai D., Leyne M., Marshall J., Nesta F., Levine R., and Slaugenhaupt S. A local for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet 72 (2003) 1551-1559
54. Disse S., Abergel E., Berrebi A., Houot A., Le Heuzey J., Diebold B., Guize L., Carpentier A., Corvol P., and Jeunemaitre X. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet 65 (1999) 1242-1251
55. Nesta F., Leyne M., Yosefy C., Simpson C., Dai D., Marshall J., Huang J., Slaugenhaupt S., and Levine R. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation 112 (2005) 2022-2030
56. Levine R., and Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution. From paradoxes to unifying concepts. Circulation 112 (2005) 745-758
57. Donal E., Levy F., and Tribouilloy C. Chronic ischemic mitral regurgitation. J Heart Valve Dis 15 (2006) 149-157
58. Borger M., Alam A., Murphy P., Doenst T., and David T. Chronic ischemic mitral regurgitation: repair, replace or rethink?. Ann Thorac Surg 81 (2006) 1153-1161
59. Schoen F. Pathology of heart valve substitution with mechanical and tissue prostheses. In: Silver M., Gotlieb A., and Schoen F. (Eds). Cardiovascular pathology. 3rd ed (2001), Churchill Livingstone 629
60. Hammermeister K., Sethi G., Henderson W., et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36 (2000) 1152-1158
61. Emery R., Krogh C., Arom K., et al. The St Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 79 (2005) 776-783
62. Schoen F., and Levy R. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 47 (1999) 439-465
63. Schoen F., and Levy R. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 79 (2005) 1072-1080
64. Abedin M., Tintut Y., and Demer L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24 (2004) 1161-1170
65. Sacks M., and Schoen F. Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res 62 (2002) 359-371
66. Vahanian A., and Palacios I. Percutaneous approaches to valvular disease. Circulation 109 (2004) 1572-1579
67. Davidson M., White J., and Baim D. Percutaneous therapies for valvular heart disease. Cardiovasc Pathol 15 (2006) 123-129
68. Lutter G., Ardehali A., Cremer J., and Bonhoeffer P. Percutaneous valve replacement: current state and future prospects. Ann Thorac Surg 78 (2004) 2199-2206
69. St. Goar F., Fann J., Komtebedde J., Foster E., Oz M., Fogarty T., Feldman T., and Block P. Endovascular edge-to-edge mitral valve repair. Short-term results in a porcine model. Circulation 108 (2003) 1990
70. Kaye D., Byrne M., Alferness C., and Powers J. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation 108 (2003) 1795
71. Khambadkone S., Coats L., Taylor A., Boudjemline Y., Derrick G., Tsang V., Cooper J., Muthurangu V., Hedge S., Razavi R., Pellerin D., Deanfield J., and Bonhoeffer P. Percutaneous pulmonary valve implantation in humans. Results in 59 consecutive patients. Circulation 112 (2005) 1189-1197
72. Cribier A., Eltchaninoff H., Tron C., Bauer F., Agatiello C., Nercolini D., Tapiero S., Litzler P.-Y., Bessou J.-P., and Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve. J Am Coll Cardiol 47 (2006) 1214-1223
73. Rabkin E., and Schoen F. Cardiovascular tissue engineering. Cardiovasc Pathol 11 (2002) 305-317
74. Langer R., and Vacanti J. Tissue engineering. Science 260 (1993) 920
75. Hoerstrup S., Sodian R., Daebritz S., Wang J., Bacha E., Martin D., Moran A., Guleserian K., Sperling J., Kaushal S., Vacanti J., Schoen F., and Mayer J. Functional living trileaflet heart valves grown in vitro. Circulation 102 (2000) III44-III49
76. Sutherland F., Perry T., Yu Y., Sherwood M., Rabkin E., Masuda Y., Garcia G., McLellan D., Engelmayr G., Sacks M., Schoen F., and Mayer J. From stem cells to viable autologous semilunar heart valve. Circulation 111 (2005) 2783-2791
77. Hoerstrup S., Cummings I., Lachat M., Schoen F., Jenni R., Leschka S., Neuenschwander S., Schmidt D., Mol A., Gunter C., Gossi M., Genoni M., and Zund G. Functional growth in tissue engineered living, vascular grafts: follow-up to 100 weeks in a large animal model. Circulation (2006) [in press]
78. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Rev 9 (2003) 702-712
79. Matheny R., Hutchison M., Dryden P., et al. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J Heart Valve Dis 9 (2000) 769-775
80. Simon P., Kasimirr M., Seebacher G., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23 (2003) 1002-1006
81. Shi Q., Rafii S., Wu M., Wijelath E., Yu C., Ishida A., Fujita Y., Kothari S., Mohle S., Sauvage L., Moore M., Storb R., and Hammond W. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
82. Frazier O., Baldwin R., Eskin S., and Duncan J. Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Tex Heart Inst J 20 (1993) 78-82
83. Aoki J., Serruys P., van Beusekom H., Ong A., McFadden E., Sianos G., van der Giessen W., Regar E., de Feyter P., Davis H., Rowland S., and Kutryk M. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointima Growth-First in Man) Registry. J Am Coll Cardiol 45 (2005) 1574-1579
84. Visconti R., Ebihara Y., LaRue A., Fleming P., McQuinn T., Masuya M., Minamiguchi H., Markwald R., Ogawa M., and Drake C. An in-vivo analysis of hematopoietic stem cell potential. Hematopoietic origin of cardiac valve interstitial cells. Circ Res 98 (2006) 690-696
85. Deb A., Wang S., Skelding K., Miller D., Simper D., and Caplice N. Bone marrow-derived myofibroblasts are present in adult human heart valves. J Heart Valve Dis 14 (2005) 674-678
86. Ota T., Sawa Y., Iwai S., Kitajima T., Ueda Y., Coppin C., Matsuda H., and Okita Y. Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve. Ann Thorac Surg 80 (2005) 1794-1801
87. Abedin M., Tintut Y., and Demer L. Mesenchymal stem cells and the artery wall. Circ Res 95 (2004) 671-676
88. Rahimtoola S. The next generation of prosthetic heart valves needs a proven track record of patient outcomes at 15 to 20 years. J Am Coll Cardiol 42 (2003) 1720-1721
89. McBrearty B., Clark L., Zhang X., Blankenhorn E., and Heber-Katz E. Genetic analysis of a mammalian wound-healing trait. Proc Natl Acad Sci U S A 95 (1998) 11792-11797
90. Weinshilboum R., and Wang L. Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 3 (2004) 739-748
91. Fernandez C., Yang L., Louis G., Yang J., Kutok J., and Moses M. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11 (2005) 5390-5395
92. Jaffer F., and Weissleder R. Molecular imaging in the clinical arena. JAMA 293 (2005) 855-862
93. Jaffer F., and Weissleder R. Seeing within: molecular imaging of the cardiovascular system. Circ Res 94 (2004) 4333-4445
94. Boecker W., Bernecker O., Wu J., Zhu X., Sawa T., Grazette L., Rosenzweig A., del Monte F., Schmidt U., and Hajjar R. Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging 3 (2004) 69-75
95. Cao F., Lin S., Xie X., Ray P., Patel M., Zhang X., Drukker M., Dylla S., Connolly A., Chen X., Weissman I., Gambhir S., and Wu J. In-vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113 (2006) 1005-1014